S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Multiple Data Presentations at the 2014 American Society of Hematology (ASH) Annual Meeting Showcase Incyte's Leadership in the Field of Myeloproliferative Neoplasms (MPNs)|
|Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer|
|Incyte Earns $60 Million Milestone Related to Reimbursement of Jakavi® (ruxolitinib) in Europe|
|Incyte to Report Third Quarter 2014 Financial Results on October 30|
|Incyte to Present at the Nomura BioPharma Conference|
|Incyte to Present at Upcoming Investor Conferences|
|FDA Approves Jakafi® (ruxolitinib) for the Treatment of Patients with Uncontrolled Polycythemia Vera|
|Incyte Reports 2014 Third-Quarter Financial Results and Updates Shareholders on Key Clinical Programs|
|Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis|
|FAA Awards Innovative Solutions & Support, Inc. STC for B737 NextGen Flight Deck and Flight Management System|
Click above to view more mutual fund data and stats for incy - Incyte Corp Ltd.